Align Technology (ALGN) Leerink Global Healthcare Conference 2026 summary

Market environment and customer dynamics

• North America has achieved greater market stability, with customers adapting to ongoing volatility from tariffs and inflation.

• DSOs are increasingly active in driving patient conversion through operational scale, technology, and local advertising.

• Individual practitioners tend to be more passive, but efforts are underway to boost their conversion rates via training and workflow enhancements.

• DSOs represent about one-third of North American revenue and are at varying stages of workflow optimization and digital adoption.

• Standardization and integration of technology and workflow are key to driving higher conversion and efficiency for DSOs.

Product innovation and portfolio evolution

• Recent launches include zero refinement cases, offering doctors and patients more flexibility and lower upfront costs.

• The product portfolio has evolved from comprehensive unlimited plans to more tailored options, such as three-in-three and zero refinement, reflecting advances in technology and digital scanning.

• Doctors now have greater choice, with the ability to select products based on their needs and patient preferences.

• The new offerings are expected to increase utilization, especially among doctors previously hesitant due to pricing gaps with traditional wires and brackets.

Pricing, margins, and financial strategy

• ASP is influenced by geographic mix and product type, with lower ASPs in fast-growing markets like Turkey, Latin America, and India.

• Lower-priced products without refinements yield higher gross margins, supporting profitability despite ASP pressure.

• The company focuses on expanding its doctor base and utilization, adapting its portfolio to meet diverse needs.

• Guidance does not factor in potential consumer stimulus or tax reform impacts, but increased refunds could benefit discretionary spending.